
Special reports
How virtual reality is giving Parkinson’s patients a ‘disease-free’ Second Life
Second Life: a (virtual) world without Parkinson’s
READ MOREA neuroscience research centre at the University of Sheffield, UK, has been recognised by Queen Elizabeth II for improving the lives of patients living with neurodegenerative conditions, including Parkinson’s.
The Sheffield Institute for Translational Neuroscience, which is based at the university, uses emerging developments in neuroscience to create innovative new approaches to treating brain conditions.
The prestigious Queen’s Anniversary Prize was awarded at St James’s Palace, London. The institute was commended for its development of Parkinson’s drug discovery programmes.
The honour is awarded to UK universities who exhibit groundbreaking and innovative approaches to research – with beneficial results at local, national and global levels.
Professor Koen Lamberts, president and vice-chancellor for the University of Sheffield, said: “As well as making life-changing discoveries today, The Sheffield Institute for Translational Neuroscience is nurturing the next generation of talented neuroscience students, whose research will lead to pioneering treatments for those living with neurological diseases.”
Read more:
Can overuse of antibiotics cause Parkinson’s?
New Parkinson’s health app to track symptoms more accurately
Second Life: a (virtual) world without Parkinson’s
READ MOREThe therapy has been acquired by pharmaceutical company STADA
READ MOREThe MJFF’s Todd Sherer discusses advances in Parkinson’s
READ MORE
Comments